David Shaw’s Lunai Bioworks LNAI Stock Holding History

David Shaw’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-806	Closed	-$124K	–	5471
2022 Q2	$124K	Buy	806 +245	+44%	+$112K	﹤0.01%	4685
2022 Q1	$370K	Sell	561 -760	-58%	-$405K	﹤0.01%	4543
2021 Q4	$770K	Buy	+1,321	New	+$959K	﹤0.01%	4126

Other funds holding LNAI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

David Shaw's LNAI Position: Q3 2022 in Review

David Shaw sold out of Lunai Bioworks (LNAI) in Q3 2022, closing a stake of 806 shares — an estimated $124K sold.

David Shaw first reported a position in LNAI in Q4 2021 and held it in 3 quarters. The position peaked at $770K in Q4 2021. 42 funds tracked by Wall St. Rank hold LNAI as of Q3 2022.

David Shaw reported no remaining Lunai Bioworks position as of Q3 2022 after selling out during the quarter.
David Shaw sold 806 Lunai Bioworks shares in Q3 2022, an estimated $124K.
David Shaw first reported a position in Lunai Bioworks in Q4 2021 and held it in 3 quarters.
David Shaw's Lunai Bioworks position peaked at $770K in Q4 2021.
42 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.